Abstract:We synthesized the chromium (phenylalanine)3 [Cr(d-phe)3] by chelating chromium(III) with d-phenylalanine ligand in aqueous solution to improve the bioavailability of chromium, and reported that Cr(d-phe)3 improved insulin sensitivity. AMP-activated protein kinase (AMPK) is a key mediator for glucose uptake and insulin sensitivity. To address the molecular mechanisms by which Cr(d-phe)3 increases insulin sensitivity, we investigated whether Cr(d-phe)3 stimulates glucose uptake via activation of AMPK signaling pathway. H9c2 myoblasts and isolated cardiomyocytes were treated with Cr(d-phe)3 (25μM). Western blotting was used for signaling determination. The glucose uptake was determined by 2-deoxy-d-glucose-3H accumulation. HPLC measured concentrations of AMP. The mitochondrial membrane potential (Δψ) was detected by JC-1 fluorescence assay. Cr(d-phe)3 stimulated the phosphorylation of α catalytic subunit of AMPK at Thr172, as well the downstream targets of AMPK, acetyl-CoA carboxylase (ACC, Ser212) and eNOS (Ser1177). Moreover, Cr(d-phe)3 significantly stimulated glucose uptake in both H9c2 cells and cardiomyocytes. AMPK inhibitor compound C (10μM) dramatically inhibited the glucose uptake stimulated by Cr(d-phe)3, while it did not affect insulin stimulation of glucose uptake. Furthermore, in vivo studies showed that Cr(d-phe)3 also activated cardiac AMPK signaling pathway. The increase of cardiac AMP concentration and the decrease of mitochondrial membrane potential (Δψ) may contribute to the activation of AMPK induced by Cr(d-phe)3. Cr(d-phe)3 is a novel compound that activates AMPK signaling pathway, which contributes to the regulation of glucose transport during stress conditions that may be associated the role of AMPK in increasing insulin sensitivity.

What Are the Implications of Cr(III) Serving as an Inhibitor of the Beta Subunit of Mitochondrial ATP Synthase?

Mitochondrial ATP synthase as a direct molecular target of chromium(III) to ameliorate hyperglycaemia stress

Targeting Mitochondrial ATP-Synthase: Evolving Role of Chromium as a Regulator of Carbohydrate and Fat Metabolism

Chromium in Human Nutrition: A Review

Toxic effect of chromium on cellular metabolism

A Newly Synthetic Chromium Complex—chromium (D-Phenylalanine)3 Activates AMP-activated Protein Kinase and Stimulates Glucose Transport

Spectroscopic and biological activity studies of the chromium-binding peptide EEEEGDD

Chromium Alters Lipopolysaccharide-Induced Inflammatory Responses Both in Vivo and in Vitro.

Mechanistic Insights from the NTP Studies of Chromium

Chromium (D-Phenylalanine)3 Supplementation Alters Glucose Disposal, Insulin Signaling, and Glucose Transporter-4 Membrane Translocation in Insulin-Resistant Mice.

Potential Ameliorative Effects of Chromium Supplementation on Glucose Metabolism, Obesity, and Genomic Stability in Prediabetic Rat Model

Dissection of the Difference Between the Group I Metal Ions in Inhibiting GSK3β: a Computational Study.

Chromium Research from a Distance: From 1959 to 1980

Antagonizing Effects of Chromium Against Iron-Decreased Glucose Uptake by Regulating ROS-Mediated PI3K/Akt/GLUT4 Signaling Pathway in C2C12

Cr (VI) induces abnormalities in glucose and lipid metabolism through ROS/Nrf2 signaling

Regulatory Effect of Trivalent Chromium on Glucose Uptake

Insights into simultaneous microbial chromium and nitrate reduction: inhibitory effects and molecular mechanisms

Chromium (d-Phenylalanine)3 alleviates high fat-induced insulin resistance and lipid abnormalities

Efficacy of Chromium(III) Supplementation on Growth, Body Composition, Serum Parameters, and Tissue Chromium in Rats

Effects of hexavalent chromium on mitochondria and their implications in carcinogenesis

Chromium Alleviates Glucose Intolerance, Insulin Resistance, and Hepatic Er Stress in Obese Mice